Oregon · 86769

Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Oregon

Oregon Medicare Avg
$39.16
5% below national avg
National Medicare Avg
$41.21
All states combined
Billed Charge (OR)
$62.52
What providers submit
Est. Commercial (OR)
$90.08
National avg: $92.31
Est. Cash / Self-Pay (OR)
$46.57
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

87
Services in OR
5
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Oregon

Provider Medicare Services
Interpath Laboratory, Inc. $39.99 57

Oregon Pricing in Context

In Oregon, CPT code 86769 (Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody) carries an average Medicare payment of $39.16 — 5% below the national benchmark of $41.21. 5 providers across the state submitted claims for this procedure in 2023, performing 87 total services. Individual payments in OR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Oregon is $62.52, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Oregon sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Oregon lands near $90.08, with self-pay cash prices typically around $46.57. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cost in Oregon?

The average Medicare payment for Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Oregon is $39.16, which is 5% below the national average of $41.21. Providers in OR typically bill $62.52 for this procedure.

What does Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cost with insurance in Oregon?

With commercial insurance in Oregon, Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody costs an estimated $90.08. Without insurance, the estimated cash price is $46.57. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Oregon?

5 providers in Oregon billed Medicare for Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in 2023, performing 87 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cheaper in Oregon than the national average?

Yes — Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody costs 5% below the national average in Oregon. The state average Medicare payment is $39.16 compared to $41.21 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial